Apogee Therapeutics, Inc. APGE
135.07 USD 0.00 (+0.00%)
At closeSep 2, 2026, 4:00 PM EDT
132.55 -2.52 -1.87%
After hours · Sep 2, 4:00 PM ET
135.06 Day range 135.09
35.39 52-week range 135.09
- YTD
- +78.95%
- 1 year
- +208.31%
Financial health
Altman Z-Score
35.08 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -17.9×
FY 2022 5y median -17.4× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 5.1×
FY 2022 5y median 4.4× FY 2025
P/FCF -19.7×
FY 2022 5y median -19.3× FY 2025
EV/EBITDA -17.5×
FY 2022 5y median -15.3× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -5.1%
FY 2022 5y median -5.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -28.3%
FY 2022 5y median -26.7% FY 2025
ROIC -31.3%
FY 2022 5y median -27.1% FY 2025
ROA -27.3%
FY 2022 5y median -25.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -31.7%
FY 2022 FY 2025
EPS (diluted) -27.9%
FY 2022 FY 2025
Free Cash Flow -35.0%
FY 2022 FY 2025
Financial Health
Current Ratio 26.6×
FY 2022 5y median 19.0× FY 2025
Quick Ratio 26.6×
FY 2022 5y median 19.0× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2022 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31